Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Para. 8 Sgb V For The Active Ingredient Omalizumab

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 92110105

  Document Type - Tender Notices

Description - Description: Section 130a Para. 8 SGB V enables health insurance companies (KK) and pharmaceutical companies to conclude framework discount agreements for the drugs dispensed at the expense of the statutory health insurance companies. GWQ acts as a c ompany for efficiency and quality in KK in accordance with Section 130a Para. 8 Sentence 5 SGBV for its shareholder and customer funds. With regard to the relevant legal provisions for the award of public contracts, a regular process of active substance-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by GWQ ServicePlus AG. The contract starts on October 1, 2024.notice_title: Conclusion Of A Non

Gt Ref Id - 92110105

Deadline - Aug 10, 2026